News
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented ...
OST-HER2 has received Rare Pediatric Disease Designation (RPDD) from the U.S. Food & Drug Administration and Fast-Track and Orphan Drug designations from the U.S. FDA and European Medicines Agency.
NEW YORK-- (BUSINESS WIRE)-- OS Therapies Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today ...
You must complete the Medicare Redetermination Request form if you’re appealing a claim denial by Medicare for the first time. This leads to the first phase of the Medicare appeals process.
MEDIPAL HOLDINGS CORPORATION Public Relations Department TEL: (+81)-3-3517-5171 JCR Pharmaceuticals Co., Ltd. Corporate Communications TEL: (+81)-797-32-1995 ...
An article published in the Times News on June 19, 2025, entitled “Panther OKs budget with slight increase,” quotes outgoing business manager Jesse Walck as saying, “the tax increase was ...
(RTTNews) - OS Therapies (OSTX) has submitted a request for Regenerative Medicine Advanced Therapy Designation to FDA for OST-HER2 in the prevention of metastases in recurrent, fully-resected ...
The National Park designation and then the pandemic have driven record tourism this spring to the Indiana Dunes, Northwest Indiana's top draw and one of the Hoosier State's most visited ...
OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request for Regenerative Medicine Advanced Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results